Lexeo starts pivotal LX2006 trial, wins RMAT for LX2020Aug 12Quarterly updateLexeo TherapeuticsLX2006
Lexeo registers Phase 2 crossover trial of LX2006 gene therapy for Friedreich ataxia cardiomyopathyJul 22Trial updateLexeo TherapeuticsLX2006
Sign inSign in